IPCIF - Intellipharmaceutics International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
11/29/2018
11/29/2017
11/29/2016
Total Revenue
3,636
1,713
5,504
2,247
Cost of Revenue
47
125
704
8,167
Gross Profit
3,589
1,588
4,800
-5,920
Operating Expenses
Research Development
8,456
10,827
9,271
-
Selling General and Administrative
4,684
3,476
3,288
3,546
Total Operating Expenses
13,672
14,914
13,066
3,931
Operating Income or Loss
-10,084
-13,326
-8,266
-9,851
Interest Expense
246
255
527
270
Total Other Income/Expenses Net
-19
9
-80
-22
Income Before Tax
-10,536
-13,747
-8,857
-10,144
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-10,536
-13,747
-8,857
-10,144
Net Income
-10,536
-13,747
-8,857
-10,144
Net Income available to common shareholders
-10,536
-13,747
-8,857
-10,144
Reported EPS
Basic
-
-2.89
-2.90
-3.80
Diluted
-
-2.89
-2.90
-3.80
Weighted average shares outstanding
Basic
-
4,762
3,101
2,670
Diluted
-
4,762
3,101
2,670
EBITDA
-
-12,880
-7,810
-9,488